A phase II, randomized, placebo-controlled study of the immunogenicity, safety and reactogenicity of an orally administered human rotavirus vaccine (RIX4414) in healthy infants in Bangladesh
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Zaman, K. | - |
| dc.date.accessioned | 2014-07-13T05:30:44Z | - |
| dc.date.available | 2014-07-13T05:30:44Z | - |
| dc.date.issued | 2004 | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/5159 | - |
| dc.format.extent | 530432 bytes | - |
| dc.format.mimetype | application/msword | - |
| dc.language.iso | en | en |
| dc.publisher | Dhaka: International Centre for Diarrhoeal Diseases Research, Bangladesh; 2004 | en |
| dc.relation.ispartofseries | icddrb research protocol no. 2004-050 | en |
| dc.subject | Clinical protocols | en |
| dc.subject | Rotavirus vaccines | en |
| dc.subject | Diarrhoeal diseases | en |
| dc.subject | Bangladesh | en |
| dc.title | A phase II, randomized, placebo-controlled study of the immunogenicity, safety and reactogenicity of an orally administered human rotavirus vaccine (RIX4414) in healthy infants in Bangladesh | en |
| dc.type | Other | en |
| Appears in Collections: | Child health research protocols | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| ICDDRBProtocol-2004-050.doc | 518 kB | Microsoft Word | View/Open |
This item is protected by original copyright |